Off-Pump Reduces Risk of Coronary Bypass Grafting in Patients with High MELD-XI Score

Abstract

Background This study aimed to assess the influence of the model of end-stage liver disease without International Normalized Ratio (INR) (MELD-XI) score on outcomes after elective coronary artery bypass surgery (CABG) without (Off-Pump) or with (On-Pump) cardiopulmonary bypass.

Methods We calculated MELD-XI (5.11 × ln serum bilirubin + 11.76 × ln serum creatinine in + 9.44) for 3,535 consecutive patients having undergone elective CABG between 2009 and 2020. A MELD-XI threshold was determined using the Youden Index based on receiver operating characteristics. Propensity score matching and logistic regression was performed to identify risk factors for inhospital mortality and Major Adverse Cardiac and Cerebrovascular Event (MACCE).

Results Patients were 68 ± 10 years old (76% male). Average MELD-XI was 10.9 ± 3.25. The MELD-XI threshold was 11. Patients below this threshold had somewhat lower EuroSCORE II than those above (3.5 ± 4 vs. 4.1 ± 4.7, p < 0.01), but mortality was almost four times higher above the threshold (below 1.5% vs. above 6.2%, p < 0.001). Two-thirds of patients received Off-Pump CABG. There was a trend towards higher risk in Off-Pump patients. Mortality was numerically but not statistically different to On-Pump below the MELD XI threshold (1.3 vs. 2.2%, p = 0.34) and was significantly lower above the threshold (4.9 vs. 8.9%, p < 0.02). Off-Pump above the threshold was also associated with less low-output syndrome and fewer strokes. Equalizing baseline differences by propensity matching verified the significant mortality difference above the threshold. Multivariable regression analysis revealed MELD-XI, On-Pump, atrial fibrillation, and the De Ritis quotient (Aspartate aminotransferase (ASAT)/Alanine Aminotransferase (ALAT)) as independent predictors of mortality.

Conclusion Elective CABG patients with elevated MELD-XI scores are at increased risk for perioperative mortality and morbidity. This risk can be significantly mitigated by performing CABG Off-Pump.

Keywords

coronary artery bypass grafts surgery - CABG - Off-Pump surgery - cardiac

Publikationsverlauf

Eingereicht: 14. Dezember 2023

Angenommen: 14. März 2024

Artikel online veröffentlicht:
23. Mai 2024

• References

• 1 Araujo L, Dombrovskiy V, Kamran W. et al. The effect of preoperative liver dysfunction on cardiac surgery outcomes. J Cardiothorac Surg 2017; 12 (01) 73
• 2 Thielmann M, Mechmet A, Neuhäuser M. et al. Risk prediction and outcomes in patients with liver cirrhosis undergoing open-heart surgery. Eur J Cardiothorac Surg 2010; 38 (05) 592-599
• 3 Kirov H, Caldonazo T, Audisio K. et al. Association of liver dysfunction with outcomes after cardiac surgery-a meta-analysis. Interact Cardiovasc Thorac Surg 2022; 35 (06) 35
• 4 Gopaldas RR, Chu D, Cornwell LD. et al. Cirrhosis as a moderator of outcomes in coronary artery bypass grafting and off-pump coronary artery bypass operations: a 12-year population-based study. Ann Thorac Surg 2013; 96 (04) 1310-1315
• 5 Adams ED, Jackson NJ, Young T, DePasquale EC, Reardon LC. Prognostic utility of MELD-XI in adult congenital heart disease patients undergoing cardiac transplantation. Clin Transplant 2018; 32 (06) e13257
• 6 Matthews JC, Pagani FD, Haft JW, Koelling TM, Naftel DC, Aaronson KD. Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation 2010; 121 (02) 214-220
• 7 Heuman DM, Mihas AA, Habib A. et al. MELD-XI: a rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl 2007; 13 (01) 30-37
• 8 Chen Y, Liu YX, Seto WK. et al. Prognostic value of hepatorenal function by modified model for end-stage liver disease (MELD) score in patients undergoing tricuspid annuloplasty. J Am Heart Assoc 2018; 7 (14) 7
• 9 Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31 (04) 864-871
• 10 Farber G, Marx J, Scherag A. et al. Risk stratification for isolated tricuspid valve surgery assisted using the Model for End-Stage Liver Disease score. J Thorac Cardiovasc Surg 2023; 166 (05) 1433-1441.e1
• 11 Dolapoglu A, Avci E, Argan O. et al. Impact of model for end-stage liver disease (MELD) score for mortality in patients undergoing coronary bypass surgery. Bratisl Lek Listy 2021; 122 (02) 125-131
• 12 Gupta S, Cogswell RJ, Roy SS. et al. Impact of 30 day readmission after left ventricular assist device implantation. ASAIO J 2019; 65 (03) 252-256
• 13 Hawkins RB, Young BAC, Mehaffey JH. et al; Investigators for the Virginia Cardiac Services Quality Initiative. Model for end-stage liver disease score independently predicts mortality in cardiac surgery. Ann Thorac Surg 2019; 107 (06) 1713-1719
• 14 Diegeler A, Börgermann J, Kappert U. et al. Five-year outcome after Off-Pump or On-Pump coronary artery bypass grafting in elderly patients. Circulation 2019; 139 (16) 1865-1871
• 15 Lamy A, Devereaux PJ, Prabhakaran D. et al; CORONARY Investigators. Five-year outcomes after Off-Pump or On-Pump coronary-artery bypass grafting. N Engl J Med 2016; 375 (24) 2359-2368
• 16 Quin JA, Wagner TH, Hattler B. et al. Ten-year outcomes of Off-Pump vs On-pump coronary artery bypass grafting in the department of veterans affairs: a randomized clinical trial. JAMA Surg 2022; 157 (04) 303-310
• 17 Ben Ari A, Elinav E, Elami A, Matot I. Off-pump coronary artery bypass grafting in a patient with Child class C liver cirrhosis awaiting liver transplantation. Br J Anaesth 2006; 97 (04) 468-472
• 18 Filsoufi F, Rahmanian PB, Castillo JG, Chikwe J, Kini AS, Adams DH. Results and predictors of early and late outcome of coronary artery bypass grafting in patients with severely depressed left ventricular function. Ann Thorac Surg 2007; 84 (03) 808-816
• 19 Kohno H, Matsumiya G. [Cardiac surgery for patients with liver cirrhosis]. Kyobu Geka 2020; 73 (10) 770-774
• 20 Biegus J, Zymliński R, Sokolski M. et al. Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure. Eur J Heart Fail 2016; 18 (12) 1518-1521
• 21 Gaudino M, Benedetto U, Bakaeen F. et al. Off- versus On-Pump coronary surgery and the effect of follow-up length and surgeons' experience: a meta-analysis. J Am Heart Assoc 2018; 7 (21) e010034
• 22 Shaefi S, Mittel A, Loberman D, Ramakrishna H. Off-Pump versus On-Pump coronary artery bypass grafting-a systematic review and analysis of clinical outcomes. J Cardiothorac Vasc Anesth 2019; 33 (01) 232-244
• 23 Di Tomasso N, Monaco F, Landoni G. Hepatic and renal effects of cardiopulmonary bypass. Best Pract Res Clin Anaesthesiol 2015; 29 (02) 151-161
• 24 Iqbal UJ, Hanif MI, Iqbal N. Effect of cardiopulmonary bypass on liver function in patients undergoing coronary artery bypass grafting. Biomedica 2015; 31: 27-29
• 25 Ascione R, Talpahewa S, Rajakaruna C. et al. Splanchnic organ injury during coronary surgery with or without cardiopulmonary bypass: a randomized, controlled trial. Ann Thorac Surg 2006; 81 (01) 97-103
• 26 Puskas J, Cheng D, Knight J. et al. Off-Pump versus conventional coronary artery bypass grafting: a meta-analysis and consensus statement from The 2004 ISMICS Consensus Conference. Innovations (Phila) 2005; 1 (01) 3-27
• 27 Tsunooka N, Maeyama K, Hamada Y. et al. Bacterial translocation secondary to small intestinal mucosal ischemia during cardiopulmonary bypass. Measurement by diamine oxidase and peptidoglycan. Eur J Cardiothorac Surg 2004; 25 (02) 275-280
• 28 Ho AM, Chan SK. Renal dysfunction and CABG. Curr Opin Pharmacol 2012; 12 (02) 181-188
• 29 Nguyen M, Tavernier A, Gautier T. et al. Glucagon-like peptide-1 is associated with poor clinical outcome, lipopolysaccharide translocation and inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass. Cytokine 2020; 133: 155182
• 30 Yamada T, Ochiai R, Takeda J, Kikuchi H, Ishibashi M, Watanabe K. Off-pump coronary artery bypass attenuates transient hepatocellular damage after myocardial revascularization. J Cardiothorac Vasc Anesth 2005; 19 (05) 603-607
• 31 Furunaga A, Tsuboi H, Okada H. et al. [Significance of AKBR as an indicator of liver injury after cardiopulmonary bypass]. Kyobu Geka 1994; 47 (13) 1055-1058